Mary L. Holtz

1.4k total citations
17 papers, 724 citations indexed

About

Mary L. Holtz is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Mary L. Holtz has authored 17 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Mary L. Holtz's work include Liver Disease Diagnosis and Treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Mary L. Holtz is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Mary L. Holtz collaborates with scholars based in United States, Netherlands and United Kingdom. Mary L. Holtz's co-authors include L. Creed Pettigrew, Susan D. Craddock, James W. Geddes, Stephen Minger, Mahin D. Maines, Nathan C. Hall, Nita H. Salzman, Jasmohan S. Bajaj, Andrew Fagan and Masoumeh Sikaroodi and has published in prestigious journals such as Hepatology, Brain Research and Developmental Biology.

In The Last Decade

Mary L. Holtz

16 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary L. Holtz United States 10 411 237 129 118 118 17 724
Junfei Zhang China 11 256 0.6× 162 0.7× 41 0.3× 120 1.0× 47 0.4× 42 619
Yo Na Kim South Korea 17 324 0.8× 118 0.5× 63 0.5× 233 2.0× 23 0.2× 39 812
Yeonhee Cho United States 11 264 0.6× 319 1.3× 18 0.1× 81 0.7× 129 1.1× 15 824
Elvira Arza Spain 11 448 1.1× 101 0.4× 35 0.3× 259 2.2× 25 0.2× 18 757
Irina M. Zemtsova Germany 11 232 0.6× 121 0.5× 77 0.6× 110 0.9× 121 1.0× 12 657
Sheng Deng China 17 279 0.7× 99 0.4× 160 1.2× 66 0.6× 13 0.1× 50 865
Ji Won Park South Korea 13 153 0.4× 142 0.6× 33 0.3× 45 0.4× 128 1.1× 65 554
Antonia Pérez-Cejas Spain 14 127 0.3× 224 0.9× 37 0.3× 50 0.4× 47 0.4× 70 534
Gunnar Brønstad Norway 15 284 0.7× 86 0.4× 58 0.4× 77 0.7× 192 1.6× 18 641

Countries citing papers authored by Mary L. Holtz

Since Specialization
Citations

This map shows the geographic impact of Mary L. Holtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. Holtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. Holtz more than expected).

Fields of papers citing papers by Mary L. Holtz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. Holtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. Holtz. The network helps show where Mary L. Holtz may publish in the future.

Co-authorship network of co-authors of Mary L. Holtz

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. Holtz. A scholar is included among the top collaborators of Mary L. Holtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. Holtz. Mary L. Holtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Frenn, Marilyn, Nita H. Salzman, Vy Lam, et al.. (2025). Childhood Obesity Body Mass Index and Gut Microbiome: A Cluster Randomized Controlled Pilot Feasibility Study. Childhood Obesity. 21(5). 489–496. 1 indexed citations
2.
Johnson, Jethro S., Amy Pan, Cynthia Behling, et al.. (2024). A serum‐induced gene signature in hepatocytes is associated with pediatric nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition. 78(4). 886–897.
3.
Zenga, Joseph, Becky Massey, Michael Stadler, et al.. (2022). A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome. EBioMedicine. 81. 104099–104099. 7 indexed citations
4.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial. Hepatology. 70(5). 1690–1703. 226 indexed citations
5.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). PS-087-Fecal microbiota capsules are safe and effective in patients with recurrent hepatic encephalopathy: A randomized, blinded, placebo-controlled trial. Journal of Hepatology. 70(1). e55–e55. 1 indexed citations
6.
Bajaj, Jasmohan S., Genta Kakiyama, Derrick Zhao, et al.. (2017). Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut–Liver Axis. Alcoholism Clinical and Experimental Research. 41(11). 1857–1865. 92 indexed citations
7.
Liu, Ta‐Chiang, Megan T. Baldridge, Richard D. Head, et al.. (2016). O-011 Paneth Cell Phenotypes Define a Subtype of Pediatric Crohnʼs Disease Through Alterations in Host-Microbial Interactions. Inflammatory Bowel Diseases. 22. S4–S4. 5 indexed citations
8.
Liu, Zhong, Suresh N. Kumar, Baofeng Zhao, et al.. (2015). Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice. Developmental Biology. 410(2). 190–201. 18 indexed citations
9.
Holtz, Mary L., et al.. (2014). Epicardial GATA factors regulate early coronary vascular plexus formation. Developmental Biology. 386(1). 204–215. 11 indexed citations
10.
Holtz, Mary L. & Ravi Misra. (2011). Serum response factor is required for cell contact maintenance but dispensable for proliferation in visceral yolk sac endothelium. BMC Developmental Biology. 11(1). 18–18. 5 indexed citations
11.
Holtz, Mary L. & Ravi Misra. (2008). Endothelial-specific ablation of Serum Response Factor causes hemorrhaging, yolk sac vascular failure, and embryonic lethality. BMC Developmental Biology. 8(1). 65–65. 16 indexed citations
12.
Pettigrew, L. Creed, Mary L. Holtz, Stephen Minger, & Susan D. Craddock. (2003). Glutamate receptor antagonists modulate heat shock protein response in focal brain ischemia. Neurological Research. 25(2). 201–207. 6 indexed citations
13.
Holtz, Mary L., Susan D. Craddock, & L. Creed Pettigrew. (2001). Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Research. 898(1). 49–60. 50 indexed citations
14.
Minger, Stephen, James W. Geddes, Mary L. Holtz, et al.. (1998). Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Research. 810(1-2). 181–199. 58 indexed citations
15.
Pettigrew, L. Creed, Mary L. Holtz, Susan D. Craddock, et al.. (1996). Microtubular Proteolysis in Focal Cerebral Ischemia. Journal of Cerebral Blood Flow & Metabolism. 16(6). 1189–1202. 115 indexed citations
16.
Geddes, James W., L. Creed Pettigrew, Mary L. Holtz, Susan D. Craddock, & Mahin D. Maines. (1996). Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase-2, protein in rat brain. Neuroscience Letters. 210(3). 205–208. 103 indexed citations
17.
Holtz, Mary L., Mark S. Kindy, Susan D. Craddock, Robert W. Moore, & L. Creed Pettigrew. (1996). Induction of PGH synthase and c-fos mRNA during early reperfusion of ischemic rat brain. Molecular Brain Research. 35(1-2). 339–343. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026